Products

Quantib ND
Quantib B.V.
Neurology AI
Quantib ND, now integrated into DeepHealth Brain, is an AI-powered medical imaging processing application designed for the analysis of brain MRI scans. It is intended to provide quantitative information to trained medical professionals for the evaluation and assessment of neurodegenerative changes. This tool is primarily for radiologists and neurologists in care settings where MRI brain […]

See all 1 product →

About Quantib B.V.

Quantib B.V. is a healthcare AI company that develops advanced radiology software designed to enhance the accuracy and efficiency of diagnostic reporting. Their solutions leverage machine learning and deep learning algorithms for the segmentation, classification, quantification, and visualization of medical images, including MRI and CT scans. This technology aims to automate and accelerate workflows, enabling physicians and researchers to make more efficient and precise diagnoses.

Quantib’s products are designed to assist radiologists and neurologists by providing quantitative information and objective assessments of medical images. Their software can detect subtle changes in tissue that might be missed by the naked eye, offering tools for automatic and semi-automatic segmentation of anatomical structures, volume computations, and standardized reporting. The company’s AI solutions are FDA-cleared and CE-marked, and are deployed through their AI Node platform, which facilitates seamless workflow integration.

Focus Areas

Medical image analysis Artificial intelligence Machine learning Deep learning Radiology Neurodegeneration Prostate cancer Breast cancer MRI analysis CT scan analysis Quantitative imaging biomarkers

Business Intelligence

TechnologyAI Node platform, cloud-native, utilizes machine learning and deep learning for segmentation, classification, quantification, and visualization of MRI and CT scans

What Physicians Need to Know

Medical Image Analysis & AI
Quantib specializes in AI-powered medical image analysis, utilizing machine learning and deep learning to enhance the accuracy and speed of diagnoses. Their solutions are FDA-cleared and CE-marked, focusing on areas like neurodegeneration and prostate cancer. They offer automated segmentation, visualization, and volumetric quantification of brain structures and white matter hyperintensities from MRI scans, as well as tools for analyzing prostate MRI scans.
Neurodegeneration
Quantib's neurodegenerative solutions, such as Quantib ND (now DeepHealth Brain), support radiologists in interpreting MRI brain scans by measuring brain atrophy (volume loss) and detecting white matter hyperintensities (WMHs). The software provides objective assessment of brain changes in longitudinal exams and compares patient brain volumes to normative databases. This aids in differentiating dementia subtypes and monitoring conditions like Alzheimer's disease and multiple sclerosis.
Prostate Cancer
Quantib Prostate (now DeepHealth Prostate) is an AI-powered software designed to assist in analyzing prostate MRI scans for enhanced prostate cancer detection. It offers tools for visualization, semi-automatic segmentation of prostate anatomy and lesions, volume computations, PSA density calculation, and PI-RADS scoring support. This streamlines the MRI reading workflow and supports standardized reporting.
Key Differentiators
Quantib's key differentiators include their focus on providing fast, objective, and accurate reports through AI solutions that are FDA-approved and CE-marked. Their solutions are vendor-independent and designed for easy integration with PACS. They leverage advanced machine learning techniques to detect tissue changes sooner than possible with the naked eye. The company originated as a spin-off from Erasmus MC, a global academic center, giving them a strong research background.
Technology Stack
Quantib's solutions are deployed through their AI Node platform, which allows for efficient workflow integration and rapid regulatory clearance. The AI Node platform is Linux-based and designed as a server-client system accessible via a web browser. Their algorithms are developed using C++ libraries and comply with standards like ISO 14971, IEC 62304, and IEC 62366 for medical device software.
Physician Tip

For physicians, Quantib's (now DeepHealth's) AI-powered solutions can significantly enhance diagnostic accuracy and efficiency. The software provides quantitative imaging biomarkers, automated segmentations, and comparative data against normative populations, leading to more objective and consistent reporting. The streamlined workflows, including one-click reporting and PI-RADS scoring support for prostate MRI, can reduce reading times and manage increasing workloads. For neurodegeneration, the ability to track changes over time and differentiate dementia subtypes offers valuable insights for personalized treatment strategies.

Quantib's solutions are designed for seamless integration with existing radiology workflows, particularly with PACS (Picture Archiving and Communication Systems). Their AI Node platform facilitates efficient deployment and interoperability. Quantib Prostate is also compatible with leading fusion biopsy systems, such as Focal Healthcare's Fusion Bx, enabling a more integrated workflow for MRI-targeted biopsies. Reports and segmentations can be directly and automatically exported to a configured DICOM node for viewing with any DICOM viewer.

Products by Quantib B.V.

1 product in the directory

Quantib ND
Quantib B.V.
Neurology AI
Quantib ND, now integrated into DeepHealth Brain, is an AI-powered medical imaging processing application designed for the analysis of brain MRI scans. It is intended to provide quantitative information to trained medical professionals for the evaluation and assessment of neurodegenerative changes. This tool is primarily for radiologists and neurologists in care settings where MRI brain […]

What the Web Says

Quantib B.V. is a company that develops AI-powered software for the analysis of medical imaging data, particularly MRI scans, to assist in diagnosis. The company was acquired by RadNet, Inc. in 2022 and became part of DeepHealth in 2023. Their products, such as Quantib Prostate and Quantib ND (now DeepHealth Prostate and DeepHealth Brain), are designed to improve diagnostic accuracy and efficiency for radiologists. While direct reviews for Quantib B.V. as an employer or specifically on platforms like G2, Glassdoor, or Capterra are limited or mixed with other similarly named companies, product-focused studies and discussions indicate a generally positive view of their technology's potential and ease of use.

Overall: Mixed

Strengths

  • AI-powered software for automatic analysis of medical imaging data.
  • Aims to shorten and improve the accuracy of diagnosis.
  • Products cleared by FDA and CE.
  • Software found easy to use by urologists in studies.
  • Potential to detect changes in tissue sooner than with the naked eye.
  • Integrates with existing diagnostic workflows.

Limitations

  • Limited direct employer reviews for Quantib B.V. specifically.
  • Some studies suggest a higher false-positive rate for autonomous AI interpretation compared to radiologists.
  • Potential for overwhelming or confusing interfaces due to high customizability (based on reviews for similarly named 'Quant' software).
  • Lack of free trials for some related software might hinder adoption (based on reviews for similarly named 'Quant' software).
  • Difficulty in generating custom reports without programming experience (based on reviews for similarly named 'Quantum' software).
  • Some general concerns about AI systems in clinical practice regarding implementation and reliance on human expertise.

Based on reviews from: DeepHealth, Trustpilot, Parsers VC, RadNet, MDPI, Jefferies Raymond James - Stifel, Spiral, Reddit, Indeed.com, G2, Capterra

Last updated: 2026-10-24

Videos

News, demos, and interviews about Quantib B.V..

Loading videos...

Videos load interactively. If none appear, search YouTube for Quantib B.V. →

View all on YouTube

Press & Coverage

BioSpace
RadNet's Quantib B.V. Subsidiary Receives FDA Clearance for its Quantib Prostate™ 3.0 Software
RadNet announced FDA clearance for Quantib Prostate™ 3.0 MRI artificial intelligence software, enhancing prostate cancer diagnosis with new and updated tools. This third-generation release aims to further support radiologists and urologists in interpreting prostate MRI scans.
2023-05
Holland Capital
Quantib has been acquired by RadNet - Holland Capital
Quantib, a leading radiology AI company focusing on clinical solutions for prostate cancer, breast cancer, and neurodegeneration, was acquired by RadNet, Inc. in January 2022. This acquisition aims to accelerate Quantib's goal of enabling more accurate and efficient clinical decision-making for millions of patients.
2022-01
AuntMinnie
Quantib releases upgrade of brain MRI software | AuntMinnie
Quantib released an upgrade to its software for MRI quantification of brain atrophy and white-matter hyperintensities, Quantib ND 2.0, designed to assist radiologists in interpreting brain MRI scans for conditions like aging, dementia, and multiple sclerosis. The upgrade includes automatic atrophy analysis.
2022-01
PubMed
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging - PubMed
This study evaluated the diagnostic performance of radiologists using Quantib Prostate AI software for prostate cancer detection at multiparametric MRI, finding it improved performance for inexperienced readers but not for those with more experience. The research was published in Radiologia Medica.
2025-05
Diagnostic Imaging
Quantib Secures FDA Clearance for AI Workflow Platform | Diagnostic Imaging
Quantib received 510(k) clearance from the FDA for its AI workflow integration platform, Quantib AI Node, a 'plug-and-play' tool designed to help radiologists process CT and MRI scans faster for more rapid diagnoses. The company also opened a New York-based office to bring its solution closer to radiologists in the US.
2020-07
Imaging Technology News
Quantib Receives FDA Clearance for First-to-Market Prostate Solution
Quantib announced FDA clearance for its prostate solution, a zero-footprint software providing a comprehensive and intuitive workflow for enhanced assessments of prostate MRI scans. This solution aims to provide powerful AI tools for radiologists in a common disease area.
2020-10
Healthcare IT News
First quantitative AI tools for medical imaging receive clearance | Healthcare IT News
Quantib received FDA clearances for Quantib™ Neurodegenerative (ND), an AI tool that assists radiologists in reading MRI brain scans by measuring brain atrophy and detecting white matter hyperintensities. This marks a significant step for AI in objective quantification in healthcare.
2019-03
Cafayate.Net
AI analytics startup Quantib raises €4.5M for better diagnoses | Cafayate.Net
Rotterdam-based AI startup Quantib raised €4.5 million in a funding round led by Holland Venture and InnovationQuarter to bring new machine learning applications to market and expand internationally. The investment will allow Quantib to develop new products beyond brain disorders, focusing on lung disorders, oncology, bone structures, and strokes.
2021-03

Frequently Asked Questions

Quantib B.V., now part of DeepHealth, offers AI-powered solutions for medical image analysis, primarily focusing on neurodegeneration and prostate cancer. Their key products include DeepHealth Brain (formerly Quantib ND and Quantib Brain) for assessing and monitoring neurodegenerative changes and DeepHealth Prostate (formerly Quantib Prostate) for enhanced prostate cancer detection.
Yes, Quantib's AI solutions are designed with compliance in mind. Their products, such as Quantib Prostate and Quantib ND, have received both FDA clearance in the United States and CE mark in Europe, indicating adherence to regulatory standards for medical devices.
Quantib's products leverage advanced machine learning and deep learning techniques to automatically analyze medical imaging data, such as MRI scans. This enables earlier detection of subtle tissue changes that might be missed by the naked eye, improving diagnostic accuracy and efficiency.
For neurodegeneration, Quantib ND (now DeepHealth Brain) provides automated segmentation and volumetric quantification of brain structures and white matter hyperintensities, offering insights into atrophy related to conditions like Alzheimer's disease and multiple sclerosis. For prostate cancer, Quantib Prostate (now DeepHealth Prostate) offers AI-based segmentations, volumetry, PSA density calculation, PI-RADS scoring support, and lesion analysis from MRI scans.
Quantib B.V. was acquired by RadNet, Inc. in 2022 and subsequently became part of RadNet's AI subsidiary, DeepHealth, in 2023. This integration suggests increased stability and resources, with Quantib's solutions now being offered under the DeepHealth brand. They have an in-house team for research and development, quality and regulatory affairs, and commercialization, indicating ongoing product development and customer support.
Quantib's solutions are deployed through their AI Node platform, which is designed for seamless workflow integration. This platform allows for efficient integration with existing systems like PACS, and the output can be compatible with other ultrasound systems, streamlining the radiology workflow and automating mundane tasks.
While Quantib's primary focus has been on neurodegeneration and prostate cancer, they were in advanced development of an AI algorithm for MRI of the breast at the time of their acquisition by RadNet. DeepHealth, the parent company, now offers breast solutions for standardizing breast cancer care across screening and diagnostic workflows, and thoracic solutions for enhanced nodule detection and reporting, which would involve CT scan analysis.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.